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Oral Presentations 19suggests that in the genetic absence of CD41 T cells, a CD8 regu-
latory population may emerge. In total, our observations support
the notion that functioning host Tregs initially occupy a niche in
the transplant recipient permitting lymphopenic expansion and an
extended period of contribution to this compartment. Notably,
this contribution reflected much greater levels than that by other
lymphoid cell populations. Overall, the findings imply that host
Treg cells may be important to consider with respect to eliciting
anti-tumor and vaccination responses in recipients during the early
period post-hematopoietic cell transplantation.45
DEVELOPMENT OF ANTIBODIES TO SELF ANTIGENS K-ALPHA-1 TUBU-
LIN AND COLLAGEN V IN PATIENTS WITH CHRONIC GRAFT VERSUS
HOST DISEASE
Pusic, I.1, Saini, D.2, Pavletic, S.Z.3, Hakim, F.3, Shannon, W.D.1,
Mohanakumar, T.2,4, DiPersio, J.F.1. 1Washington University School
of Medicine, St. Louis, MO; 2Washington University School of Medicine,
St. Louis, MO; 3National Institutes of Health, Bethesda, MD; 4Wash-
ington University School of Medicine, St. Louis, MO.
Background:ChronicGraft vs.HostDisease (cGVHD) is amul-
tisystem alloimmune and autoimmune disorder characterized by
production of antibodies, immune dysregulation and impaired or-
gan function resembling autoimmune diseases. NIH Consensus
Criteria for cGVHD (Filipovich et al, BBMT 11:945, 2005) defines
bronchiolitis obliterans (BO) diagnosed clinically as a distinctive
feature (seen in cGVHDbut insufficient alone to establish the diag-
nosis) and BO diagnosed by lung biopsy as a diagnostic feature of
cGVHD (sufficient to establish the diagnosis). Chronic rejection
following human lung transplantation is strongly associated with
development of alloimmune response to donor mismatched HLA
antigens. Recent studies in our laboratory and others have shown
a strong correlation between development of autoimmunity to self
antigens K-alpha-1 tubulin and collagen V with tissue damage
and immunopathogenesis of chronic rejection characterized by
BO. In this study, we analyzed the presence of antibodies to self-an-
tigens K-alpha-1 tubulin and collagen V in patients with cGVHD.
Methods: Serum samples from patients with cGVHD were ana-
lyzed for antibodies which bind to human recombinant purified
K-alpha-1 tubulin (1 mcg/ml) and collagen V using ELISA assays.
Analysis of variance was used to compare the means of different
groups with p\0.05 as an indicator of strong association. Results:
Study includes 21 patients with cGVHDdeveloping after allogeneic
transplantation for hematological malignancies and 10 normal con-
trols. 11 patients with cGVHD had lung involvement by NIH Cri-
teria with minimal lung score of 2. Levels of K-alpha-1 tubulin
antibodies were higher in patients with lung cGVHD when com-
pared to patients without lung involvement or normal controls (p
5 0.027). Levels of Collagen V antibodies were higher in patients
with lung cGVHD when compared to normal controls (p 5
0.025) but not when compared to patients without cGVHD of the
lung. 64% of patients with lung involvement by cGVHD developed
antibodies to both antigens and 82% had antibodies to at least one.
Conclusion: In this preliminary analysis development of antibodies
to K-alpha-1 tubulin and to collagen V appears to be highly associ-
ated with cGVHD and the highest titer autoantibodies are seen in
those patients with lung involvement. Studies are underway to de-
fine the kinetics of these antibodies after transplantation and their
incidence and titers in allogeneic stem cell recipients without clin-
ical signs of cGVHD.46
ANDROGEN WITHDRAWAL MODULATES THYMOPOIESIS BY INDUCING
THYMIC EPITHELIAL CELL PROLIFERATION AND INCREASING PRECUR-
SOR NICHE
Williams, K.M., Lucas, P.J., Bare, C.V., Wang, J., Chu, Y.-W.,
Gress, R.E. National Institutes of Health/National Cancer Institute,
Bethesda, MD.Impaired thymopoiesis contributes to immune deficiency follow-
ing allogeneic stem cell transplantation. Emerging clinical literature
suggests that graft-versus-host disease may be exacerbated and
graft-versus-leukemia effect compromised in the setting of thymic
insufficiency. Data have demonstrated that the thymus is damaged
following the transplant preparative regimen, with a depletion of
UEA1 thymic epithelial cells. We show that castration of male
mice results in thymic renewal, as demonstrated by increased thy-
mocyte number, intrathymic T cell receptor excision circles, and
the number of early thymic progenitors (ETP: Lin- CD25- c-kit
hi CD44 hi) as early as eight days post-castration. These observa-
tions suggested a mechanism of enhanced thymopoieis that occurs
through increased immigration of thymocyte precursors. Studies
with adoptively transferred congenic marrow progenitors confirm
that enhanced ETP immigration is an early event following andro-
gen withdrawal. Data also demonstrate a significant increase in
UEA1 thymic epithelial cell proliferation by BRDU1 incorpora-
tion in the initial time frame following castration, implicating thy-
mic epithelial cell proliferation in this thymic expansion, and
suggesting that there may be an increase in thymic niche regulating
ETP uptake.We have further identified an increase in a stromal de-
rived protein important for ETP uptake by Western blot in total
thymus lysates consistent with a mechanism of an increased ETP
niche. Preliminary data also suggest that the mRNA encoding this
protein is increased in sorted thymic epithelial subsets, with the
greatest increase in the UEA1 medullary TEC cells, implicating
these medullary epithelial cells in ETP entry. Taken together, we
show that androgen withdrawal leads to UEA1medullary cell pro-
liferation with augmented ETP niche and entry. Thus, we identify
ETP uptake as a critical and dynamically controlled point of thymic
regulation.LATE EFFECTS/QUALITY OF LIFE47
PROSPECTIVE NEUROCOGNITIVE FUNCTION AND RISK FACTORS AT 5
YEARS AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
(HCT) FOR HEMATOLOGIC MALIGNANCIES, COMPARED WITH CON-
TROLS AT 5 YEARS
Syrjala, K.L.1,2, Artherholt, S.B.1, Kurland, B.F.1, Langer, S.L.1,2,
Martin, P.J.1,2, Roth-Roemer, S.3, Abrams, J.R.1, Elrod, J.B.2,
Dikmen, S.2. 1Fred Hutchinson Cancer Research Center, Seattle, WA;
2University of Washington, Seattle, WA; 3Arizona Medical Psychology,
Scottsdale, AZ.
Investigators have documented significant cognitive decline after
high dose treatment followed by allogeneic HCT. We have deter-
mined that partial recovery occurs by 1 year, but deficits remain
in verbal capacity and motor skills. Our current aims were to deter-
mine the extent of long-term cognitive dysfunction, and risk factors
for deficits at 5 years.We hypothesized improvement between 1 and
5 years, and that risk factors would include type of treatment before
transplant, and duration of immunosuppressant medications. A to-
tal of 142 adults completed neuropsychological tests for verbal
memory (Hopkins Verbal Learning Test; HVLT), verbal fluency
(Controlled Oral Word Association Test; COWAT), information
processing (Digit Symbol and Trail Making B; Trails B) and motor
dexterity and speed (Grooved Pegboard), among other tests. Survi-
vors were re-tested after 80 days, and 1 and 5 years post-transplant.
A neuropsychologist traveled to test each of N5 66 5 year survivors
and case-matched controls in person. Generalized estimating equa-
tions indicated significant changes over time frompretransplant to 5
years in all tests except memory (P\ .0001; memory P 5 .17). Be-
tween 1 and 5 years, verbal fluency continued to improve (P5 .001),
as did information processing (P\ .01); but motor dexterity and,
memory did not (P . .65), remaining below controls (P\ .0001
motor dexterity, P 5 .060 verbal memory). Table 1 indicates the
percent impaired (t score # 40) at 5 years. The only identified
risk factor for poorer verbal memory at 5 years was history of intra-
thecal chemotherapy or cranial irradiation (95% Confidence Inter-
val (CI) 0.71, 15.13, P 5 .03). Risk factors for impaired motor
dexterity and speed at 5 years included immunosuppression longer
20 Oral Presentationsthan 12 months (Odds Ratio (OR) 3.7, CI 1.1, 11.8, P 5 .03) and
emotional distress pretransplant (OR 2.7, CI 1.0, 7.1, P5 .05). Re-
sults indicate that neuropsychological function continued to im-
proved from 1 to 5 years, but deficits remained for a third or
more of survivors in memory and motor dexterity.Impairment Rates at 5 Years
5 Year Survivors 5 Year Controls
Test % Impaired* % Impaired*Motor speed and dexterity
(Pegboard)43 17Verbal memory (HVLT) 32 20
Verbal fluency (COWAT) 20 14
Information processing
(Digit Symbol/Trails B)12/15 6/8*T scores in normative samples would have 15% impaired.48
A SIMPLIFIED SCORING SYSTEM TO PREDICT DAY 100 NON-RELAPSE
MORTALITY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
Basu, S.K.1, Liesveld, J.L.1, Trawick, D.R.2, Fernandez, D.3,
Nichols, D.1, Fisher, S.G.3. 1University of Rochester, Rochester, NY;
2University of Rochester, Rochester, NY; 3University of Rochester, Roches-
ter, NY.
This study’s purpose was to develop a scoring system using pa-
tient characteristics before hematopoietic stem cell transplantation
(HSCT) to predict the risk of early non-relapse mortality.
Methods: Patients undergoing their first HSCT at the Univer-
sity of Rochester from 1995 to 2004 were eligible. Non-relapse
mortality at 100 days (Day100NRM) was the primary outcome.
Sex, race, age, smoking status, body mass index, diagnosis, year,
transplant type, cell source, conditioning regimen, dose of nucle-
ated cells, diffusion capacity of the lung for carbon monoxide
(DLCO), forced expiratory volume at one second, forced vital ca-
pacity, creatinine, BUN, bilirubin, serum aspartate aminotransfer-
ase (AST), left ventricular ejection fraction, and albumin were
evaluated as independent variables. The study population was ran-
domly divided into two samples: an exploratory sample to construct
a prediction model with risk factors for Day100NRM and a valida-
tion sample to test this model. Results: Data regarding patient
characteristics were available on 677 (95%) patients. 507 subjects
(75%) were randomly selected to form the exploratory sample. Us-
ing logistic regression, related and unrelated allogeneic (versus au-
tologous) transplant, stem cells from bone marrow (versus
peripheral blood), low DLCO, low albumin, and high AST were
identified as statistically significant predictors of Day100NRM in
the exploratory sample (c-statistic 5 0.856). This model was suc-
cessfully validated (c-statistic 5 0.819) on the remaining 170 sub-
jects (validation sample) and on three random sub-samples of the
exploratory sample. Next, receiver operating characteristic curves
and classification tables were used to identify optimal cut-off points
to dichotomizeDLCO (\65,$65%predicted, corrected for hemo-
globin), AST (.40, #40 IU/L)) and albumin (\3.5, $3.5 g/dl) to
construct a scoring system for clinical use. This prediction model
was used to categorize patients into three groups- low, moderate,
or high risk of Day100NRM (see Table). There was an incremental
increase in risk of Day100NRM (2%, 13%, 39%) across the risk
groups. Conclusions: Type of transplant, stem cell source,
DLCO, AST, and albumin were predictive of Day100NRM, and
were used to construct a simplified scoring system. This pre-trans-
plant risk scoring system may be used for prognostication, and per-
haps to institute risk based targeted therapies. External validation is
necessary to determine its generalizability to other populations.Scoring System
Variable Variable ScoreDLCO (% predicted):\65 1
$65 0




Stem Cell source: Bone Marrow 1
Peripheral blood 0
Transplant: Unrelated donor 2
Related Donor 1
Autologous 0
Risk Group Total Score
Low Risk 0, 1
Moderate Risk 2
High Risk $349
RURAL-URBAN DISPARITIES IN SURVIVAL OUTCOME AFTER HEMATO-
POIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIG-
NANCIES
Rao, K.1, Darrington, D.L.2, Schumacher, J.J.2, DeVetten, M.P.2,
Vose, J.M.2, Loberiza, F.R.2. 1Brownell Talbott High School, Omaha,
NE; 2University of Nebraska Medical Center, Omaha, NE.
Background: We evaluated whether a patient’s area of primary
residence is an independent risk factor for overall survival (OS) after
HLA-identical sibling or autologous hematopoietic stem cell trans-
plantation (HSCT). Patients andMethods:This is a retrospective
study that included patients who received autologous HSCT (n 5
1739) for lymphoma and multiple myeloma (MM) or HLA-identi-
cal sibling (n5 267)HSCT for leukemias between 1983 and 2004 at
the University of Nebraska Medical Center. Primary area of resi-
dence using the patient’s zip code was categorized as either urban
or rural according to the Rural Urban Commuting Area Codes clas-
sifications. Association between area of primary residence and OS
was examined using Cox Proportional Hazards regression analysis
to adjust for other prognostic variables. The role of distance from
transplant center and average income were also explored. Results:
Patients coming from rural areas weremore likely to be: older, Cau-
casians, live at least 100 miles away, and have an average income
lower than $50K compared to patients coming from urban areas.
More rural patients are transplanted forMM, otherwise distribution
of diseases and disease stages were similar between the two areas.
The number of transplants performed in patients coming from rural
areas increased in the recent years. In the univariate analysis the fol-
lowing were associated with increased risk of death: patients from
rural areas, patients living more than 100 miles away, and patients
with income lower than $50K Inmultivariate analysis, among recip-
ients of autologous HSCT, patients from rural areas had an in-
creased risk of death (RR 1.18, P 5 0.016) compared to patients
from urban areas after adjusting for age, disease stage and time pe-
riod of transplant. The effect of distance and income dissipated.
Survival rates between rural and urban locations are: at 1 year
(73% vs. 78%, P 5 0.04) and at 5 years (48% vs. 54%, P 0.012).
We failed to detect a significant difference in the risk of death ac-
cording to area of residence in theHLA-identical siblingHSCT co-
hort, although this may be due to lack of statistical power.
Conclusion: The primary location of a patient’s residence may be
an independent risk factor for survival after HSCT. Specific issues
regarding the coordination of follow-up care of patients from rural
areas, as well as their health behavior and medical utilization pat-
terns post-HSCT should be studied prospectively.
